insights_auto
Why is VTGN down 10.36%?
Dive Deeperchevron_right
VTGN:NASDAQ
Vistagen Therapeutics Inc
$0.17
arrow_downward
-10.36%(-0.019) 1D
$0.16
arrow_downward
-1.33% (-0.0022)todayPre-market
Closed: Nov 5, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VTGN...
Open
$0.18
High
$0.18
Low
$0.17
Mkt. cap
7.51M
Avg. vol.
2.00M
Volume
4.15K
52-wk high
$5.14
52-wk low
$0.17
EPS
-$1.68
Beta
0.49
Shares outstanding
44.38M
No. of employees
41
Open
$0.18
High
$0.18
Low
$0.17
Mkt. cap
7.51M
Avg. vol.
2.00M
Volume
4.15K
52-wk high
$5.14
52-wk low
$0.17
EPS
-$1.68
Beta
0.49
Shares outstanding
44.38M
No. of employees
41
News stories
From web sources and news partners
marketscreener.com
·
22 minutes ago
Out of the blue
Yahoo Finance
·
59 minutes ago
Invesco S&P 500 Equal Weight (RSP) Adds Okta and Moderna on Nov. 4
TradingView
·
1 hour ago
Stock Market Today: Dow Jones, S&P 500 Futures Trade Mixed Ahead of October's Jobs Report— Airbnb, Cloudflare, Lam Research in Focus
The Motley Fool
·
2 hours ago
Meet the Unstoppable Vanguard ETF Beating the S&P 500 and the Dow Jones in 2026
About Vistagen Therapeutics Inc
CEO-
Employees41
Founded1998
HeadquartersSouth San Francisco, California, United States
SectorHealth Care
IndustryBiotechnology
Websitevistagen.com